Treatment

To help achieve desired results, patients should complete all three treatment sessions3

Treatment Day 1. Treatment Day 22. Treatment Day 43.
Treatment Day 1. Treatment Day 22. Treatment Day 43.

Each treatment

Patients may receive up to 12 injections per buttock, for a maximum of 24 injections for both buttocks.3

Some dimples may require more than one injection.1,10

A visualization of the injection sites.
A visualization of the injection sites.

QWO injection technique:3

This injection technique is for the buttocks only.

  • Use a 1 mL syringe with a 30 g 1/2” needle.
  • Do NOT remove the needle from the injection site during the three-part injection – gently pull the needle back and reposition it.
Decorative butt

Three-part injection technique:3

VIDEO TRANSCRIPT: ​​Looping video depicting a needle penetrating dermis.
Play video

QWO is supplied as a sterile, preservative-free lyophilized powder in a single-use vial that must be reconstituted before use.3

0.92 mg QWO vial and 4 mL diluent.
0.92 mg QWO vial and 4 mL diluent.
0.92 mg vial
4 mL diluent
Up to 12 injections*

or

1.84 mg QWO vial and 8 mL diluent.
1.84 mg QWO vial and 8 mL diluent.
1.84 mg vial
8 mL diluent
Up to 24 injections*

*There is a maximum of 12 injections per buttock, per treatment.

Clinical Education Center

Here you will find additional information and resources.

Carousel items

  1. The science of cellulite.

    Science of cellulite

    Find important learnings on the
    science of cellulite

    Learn More
  2. Product information.

    Product information

    Find valuable discussions and data
    pertaining to cellulite and QWO

    Learn More
  3. Publications and presentations.

    Publications & presentations

    Read up on a variety of publications
    and presentations on QWO

    Learn More
  4. Clinical practice.

    Clinical practice

    Find information on QWO usage
    and best practices

    Learn More

What to expect with QWO

Learn more about the safety of QWO and what your patients should expect post-treatment.

Safety
Safety
Clinical Education Center

Indication

Qwo® is indicated for the treatment of moderate to severe cellulite in the buttocks of adult women.

Important Safety Information for QWO

Contraindications

QWO is contraindicated in patients with a history of hypersensitivity to collagenase or to any of the excipients or the presence of infection at the injection sites.

Warnings and Precautions

Hypersensitivity Reactions

Serious hypersensitivity reactions including anaphylaxis have been reported with the use of collagenase clostridium histolyticum. If such a reaction occurs, further injection of QWO should be discontinued and appropriate medical therapy immediately instituted. Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions.

Injection Site Bruising

In clinical trials, 84% of subjects treated with QWO experienced injection site bruising. Subjects with coagulation disorders or using anticoagulant or antiplatelet medications (except those taking ≤150 mg aspirin daily) were excluded from participating in Trials 1 and 2.

QWO should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet (except those taking ≤150 mg aspirin daily) or anticoagulant therapy.

Substitution of Collagenase Products

QWO must not be substituted with other injectable collagenase products.

QWO is not intended for the treatment of Peyronie’s Disease or Dupuytren’s Contracture.

Adverse Reactions

In clinical trials, the most commonly reported adverse reactions in patients treated with QWO with an incidence ≥ 10% were at the injection site: bruising, pain, nodule and pruritus.

View Full Prescribing Information for QWO.